Evidence map›Paper›PMID 40624323›Full record

ArticleJournal of general internal medicine2026

"Medical Cannabis": Advising Patients While Navigating Medical Ethics and Limited Evidence.

Anna-Maria South, Shanna L Babalonis, Laura C Fanucchi, Michelle R Lofwall

Abstract readEditorial
In one paragraph

Article in Journal of general internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anna-Maria SouthDepartment of Internal Medicine, Division of Hospital Medicine, Addiction Consult and Education Service, College of Medicine, University of Kentucky, 800 Rose Street, Lexington, KY, 40536, USA. aso248@uky.edu.ORCID 0009-0004-3582-3506
Shanna L BabalonisDepartment of Behavioral Science, Center On Drug and Alcohol Research and Cannabis Center, College of Medicine, University of Kentucky, Lexington, KY, USA.
Laura C FanucchiDepartment of Internal Medicine, Division of Infectious Diseases, Center On Drug and Alcohol ResearchCollege of Medicine, Addiction Consult and Education Service, University of Kentucky, Lexington, KY, USA.
Michelle R LofwallDepartment of Behavioral Science and Psychiatry, Center On Drug and Alcohol Research, College of Medicine, University of Kentucky, Lexington, KY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cannabis is increasingly legalized in more areas of the USA and marketed under the misnomer "medical cannabis." Yet, there are no official dosing guidelines or approved medical uses for plant cannabis by the Food and Drug Administration. Due to significant federal barriers, research on efficacy, safety, and adverse effects of cannabis is limited. Patients are interested in cannabis as potential treatment of medical issues and/or symptoms and clinicians should include a discussion of the risks of cannabis consumption. However, many risks are not yet known, and clinicians might be unaware of the emerging literature. This perspective summarizes the potential harms of cannabis, including the risk of cannabis use disorder, while providing a framework grounded in principles of medical ethics to educate patients on cannabis.

Indexed as

Ethics, MedicalMedical MarijuanaPatient Education as TopicHumansUnited StatesMedical Marijuana

Identifiers

PMID40624323
PMCPMC12894469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.